Búsqueda | Biblioteca Virtual en Salud

1.

CARDIOVASCULAR SCREENING OF YOUNG ATHLETES: A REVIEW OF ECONOMIC EVALUATIONS.

Gerkens, Sophie; Van Brabandt, Hans; Desomer, Anja; Leonard, Christian; Neyt, Mattias.

Int J Technol Assess Health Care ; 33(1): 76-83, 2017 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-28436336

2.

Effectiveness of catheter ablation of atrial fibrillation in Belgian practice: a cohort analysis on administrative data.

Van Brabandt, Hans; Neyt, Mattias; Devos, Carl.

Europace ; 15(5): 663-8, 2013 May.

Artículo en Inglés | MEDLINE | ID: mdl-23388182

3.

The cost-utility of catheter ablation of atrial fibrillation: a systematic review and critical appraisal of economic evaluations.

Neyt, Mattias; Van Brabandt, Hans; Devos, Carl.

BMC Cardiovasc Disord ; 13: 78, 2013 Sep 26.

Artículo en Inglés | MEDLINE | ID: mdl-24070126

4.

Legal and organizational aspects of remote cardiac monitoring: the example of implantable cardioverter defibrillators.

Vinck, Imgard; De Laet, Chris; Stroobandt, Serge; Van Brabandt, Hans.

Europace ; 14(9): 1230-5, 2012 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-22345377

5.

Pre-market clinical evaluations of innovative high-risk medical devices in Europe.

Hulstaert, Frank; Neyt, Mattias; Vinck, Imgard; Stordeur, Sabine; Huic, Mirjana; Sauerland, Stefan; Kuijpers, Marja R; Abrishami, Payam; Vondeling, Hindrik; Flamion, Bruno; Garattini, Silvio; Pavlovic, Mira; van Brabandt, Hans.

Int J Technol Assess Health Care ; 28(3): 278-84, 2012 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-22980705

6.

Cost effectiveness of drug-eluting stents in Belgian practice: healthcare payer perspective.

Neyt, Mattias; De Laet, Chris; De Ridder, Annemieke; Van Brabandt, Hans.

Pharmacoeconomics ; 27(4): 313-27, 2009.

Artículo en Inglés | MEDLINE | ID: mdl-19485427

7.

Safety of percutaneous aortic valve insertion. A systematic review.

Van Brabandt, Hans; Neyt, Mattias.

BMC Cardiovasc Disord ; 9: 45, 2009 Sep 01.

Artículo en Inglés | MEDLINE | ID: mdl-19723312

8.

Cost-effectiveness analyses of drug eluting stents versus bare metal stents: a systematic review of the literature.

Neyt, Mattias; Van Brabandt, Hans; Devriese, Stephan; De Laet, Chris.

Health Policy ; 91(2): 107-20, 2009 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-19135756

9.

Percutaneous pulmonary and aortic valve insertion in Belgium: going for conditional reimbursement or waiting for further evidence?

Neyt, Mattias; Vinck, Imgard; Gewillig, Marc; Van Brabandt, Hans.

Int J Technol Assess Health Care ; 25(3): 281-9, 2009 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-19619346

10.

Testing the HTA core model: experiences from two pilot projects.

Pasternack, Iris; Anttila, Heidi; Mäkelä, Marjukka; Ikonen, Tuija; Räsänen, Pirjo; Lampe, Kristian; van Brabandt, Hans; Cleemput, Irina; de Laet, Chris; Marchetti, Marco; Refolo, Pietro; Sacchini, Dario; Kunz, Regina; Nordmann, Alain; Lühmann, Dagmar; Freyschuss, Bo.

Int J Technol Assess Health Care ; 25 Suppl 2: 21-7, 2009 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-20030887

11.

Cost-effectiveness of statins in the primary prevention of cardiovascular disease: a systematic review and economic analysis for Belgium.

Neyt, Mattias; De Laet, Chris; Van Brabandt, Hans; Franco, Oscar; Ramaekers, Dirk.

Acta Cardiol ; 64(1): 1-10, 2009 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-19317290

12.

Questionable levels of evidence in new atrial fibrillation guidelines?

Van Brabandt, Hans; Neyt, Mattias; Devos, Carl.

Europace ; 15(3): 461, 2013 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-23194698

13.

Health technology assessment on catheter ablation of atrial fibrillation in Belgium.

Van Brabandt, Hans; Neyt, Mattias; Devos, Carl.

Europace ; 15(5): 618-9, 2013 May.

Artículo en Inglés | MEDLINE | ID: mdl-23625940

14.

Cost effectiveness of implantable cardioverter-defibrillators for primary prevention in a Belgian context.

Neyt, Mattias; Thiry, Nancy; Ramaekers, Dirk; Van Brabandt, Hans.

Appl Health Econ Health Policy ; 6(1): 67-80, 2008.

Artículo en Inglés | MEDLINE | ID: mdl-18774871

15.

The use of instrumental variables: an alternative to traditional modeling?

Neyt, Mattias; Van Brabandt, Hans; De Laet, Chris.

Value Health ; 14(1): 1-2, 2011 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-21211480

16.

Systematic Review of the Efficacy and Safety of High-intensity Focussed Ultrasound for Localised Prostate Cancer.

Veereman, Geneviéve; Jonckheer, Pascale; Desomer, Anja; Van Brabandt, Hans; D'Hont, Chris; Van Velthoven, Roland; Tombal, Bertrand.

Eur Urol Focus ; 1(2): 158-170, 2015 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-28723429

17.

Pitfalls in health-economic evaluations: the case of cost-effectiveness of prophylactic implantable cardioverter-defibrillator therapy in Belgium.

Van Brabandt, Hans; Neyt, Mattias.

Europace ; 11(12): 1571-3, 2009 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-19819879

18.

Are thrombolytic drugs not evidence-based medications?

Van Brabandt, Hans; Vrijens, France.

Arch Intern Med ; 168(2): 239-40; author reply 240-1, 2008 Jan 28.

Artículo en Inglés | MEDLINE | ID: mdl-18227377

19.

Recommendations or mere prose?

Van Brabandt, Hans.

Eur Heart J ; 29(11): 1473; author reply 1473-4, 2008 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-18445703

20.

Multidisciplinary outpatient rehabilitation following cardiac revascularization or valve surgery: patient-related factors for uptake.

Strens, Daniëlle; Colle, An; Vrijens, France; Paulus, Dominique; Eyssen, Maria; Van Brabandt, Hans; Van Vlaenderen, Ilse.

Eur J Prev Cardiol ; 20(3): 422-30, 2013 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-22392164

Biblioteca Virtual en Salud

Hipertensión

Su selección (0)

Formato de exportación:

Exportar:

CARDIOVASCULAR SCREENING OF YOUNG ATHLETES: A REVIEW OF ECONOMIC EVALUATIONS.

Effectiveness of catheter ablation of atrial fibrillation in Belgian practice: a cohort analysis on administrative data.

The cost-utility of catheter ablation of atrial fibrillation: a systematic review and critical appraisal of economic evaluations.

Legal and organizational aspects of remote cardiac monitoring: the example of implantable cardioverter defibrillators.

Pre-market clinical evaluations of innovative high-risk medical devices in Europe.

Cost effectiveness of drug-eluting stents in Belgian practice: healthcare payer perspective.

Safety of percutaneous aortic valve insertion. A systematic review.

Cost-effectiveness analyses of drug eluting stents versus bare metal stents: a systematic review of the literature.

Percutaneous pulmonary and aortic valve insertion in Belgium: going for conditional reimbursement or waiting for further evidence?

Testing the HTA core model: experiences from two pilot projects.

Cost-effectiveness of statins in the primary prevention of cardiovascular disease: a systematic review and economic analysis for Belgium.

Questionable levels of evidence in new atrial fibrillation guidelines?

Health technology assessment on catheter ablation of atrial fibrillation in Belgium.

Cost effectiveness of implantable cardioverter-defibrillators for primary prevention in a Belgian context.

The use of instrumental variables: an alternative to traditional modeling?

Systematic Review of the Efficacy and Safety of High-intensity Focussed Ultrasound for Localised Prostate Cancer.

Pitfalls in health-economic evaluations: the case of cost-effectiveness of prophylactic implantable cardioverter-defibrillator therapy in Belgium.

Are thrombolytic drugs not evidence-based medications?

Recommendations or mere prose?

Multidisciplinary outpatient rehabilitation following cardiac revascularization or valve surgery: patient-related factors for uptake.